Document Detail

Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.
Jump to Full Text
MedLine Citation:
PMID:  11384525     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In 1999, 23% of Salmonella enterica serotype Typhi isolates from patients in the United Kingdom exhibited decreased susceptibility to ciprofloxacin (MIC 0.25-1.0 mg/L); more than half were also resistant to chloramphenicol, ampicillin, and trimethoprim. Increasing numbers of treatment failures have been noted. Most infections have been in patients with a recent history of travel to India and Pakistan.
Authors:
E J Threlfall; L R Ward
Related Documents :
18590455 - Effect of a program to reduce hospital ciprofloxacin use on nosocomial pseudomonas aeru...
15013045 - In vitro activity of gemifloxacin and contemporary oral antimicrobial agents against 27...
19833635 - In vitro activity of nemonoxacin (tg-873870), a novel non-fluorinated quinolone, agains...
2111135 - Mutation rates to 4-quinolone resistance.
12450145 - Inhibition of proteasome activity by tyropeptin a in pc12 cells.
15338455 - Comparative analysis of trehalose production by debaryomyces hansenii and saccharomyces...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Emerging infectious diseases     Volume:  7     ISSN:  1080-6040     ISO Abbreviation:  Emerging Infect. Dis.     Publication Date:    2001 May-Jun
Date Detail:
Created Date:  2001-05-31     Completed Date:  2001-07-05     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  9508155     Medline TA:  Emerg Infect Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  448-50     Citation Subset:  IM    
Affiliation:
Central Public Health Laboratory, London, United Kingdom. jthrelfall@phls.nhs.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Infective Agents / pharmacology*
Ciprofloxacin / pharmacology*
Drug Resistance, Microbial
Drug Resistance, Multiple
Humans
Microbial Sensitivity Tests
Salmonella typhi / drug effects*
Chemical
Reg. No./Substance:
0/Anti-Infective Agents; 85721-33-1/Ciprofloxacin
Comments/Corrections
Comment In:
Emerg Infect Dis. 2001 Jul-Aug;7(4):762-3   [PMID:  11585550 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Emerg Infect Dis
Journal ID (pmc): eid
ISSN: 1080-6040
ISSN: 1080-6059
Publisher: Centers for Disease Control
Article Information
Download PDF

Print publication date: Season: May?Jun Year: 2001
Volume: 7 Issue: 3
First Page: 448 Last Page: 450
ID: 2631792
PubMed Id: 11384525

Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.
E. J. Threlfall Email: jthrelfall@phls.nhs.uk
L. R. Ward
Central Public Health Laboratory, London, United Kingdom.


Article Categories:
  • Research Article


Previous Document:  Expanding drug resistance through integron acquisition by IncFI plasmids of Salmonella enterica Typh...
Next Document:  Reiter syndrome following protracted symptoms of Cyclospora infection.